ELEVAR THERAPEUTICS

Serial Number 88985348
Registration 7579989
700

Registration Progress

Application Filed
Sep 16, 2019
Under Examination
Jun 15, 2021
Approved for Publication
Apr 20, 2021
Published for Opposition
Apr 20, 2021
Registered
Nov 26, 2024

Trademark Image

ELEVAR THERAPEUTICS

Basic Information

Serial Number
88985348
Registration Number
7579989
Filing Date
September 16, 2019
Registration Date
November 26, 2024
Published for Opposition
April 20, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Nov 26, 2024
Registration
Registered
Classes
042

Rights Holder

Elevar Therapeutics, Inc.

03
Address
2825 East Cottonwood Parkway, Suite 180
Salt Lake City, UT 84121

Ownership History

Elevar Therapeutics, Inc.

Original Applicant
03
Salt Lake City, UT

Elevar Therapeutics, Inc.

Owner at Publication
03
Salt Lake City, UT

Elevar Therapeutics, Inc.

Original Registrant
03
Salt Lake City, UT

Legal Representation

Attorney
Cynthia Walden

USPTO Deadlines

Next Deadline
1805 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20241126)
Due Date
November 26, 2030
Grace Period Ends
May 26, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Nov 26, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Nov 26, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 16, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Feb 15, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 14, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 23, 2023 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 22, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 13, 2023 IUAF S USE AMENDMENT FILED Loading...
Dec 22, 2023 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Dec 13, 2023 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Dec 13, 2023 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Dec 13, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 13, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 9, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 7, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jun 7, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 7, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 10, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2022 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 8, 2022 EXT3 S SOU EXTENSION 3 FILED Loading...
Dec 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 17, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 15, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 15, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 15, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jun 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Dec 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 15, 2021 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 15, 2021 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 15, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 15, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 20, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 20, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 31, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 12, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 10, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 9, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 19, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 19, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Jan 19, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 16, 2021 EXPT T EXPARTE APPEAL TERMINATED Loading...
Jan 15, 2021 ZZAX Z PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU Loading...
Jan 15, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 18, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 18, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...

Detailed Classifications

Class 042
Medical and scientific research; conducting clinical trials for others in the field of cancer therapeutics, distributed primarily to healthcare professionals; research and development in the field of cancer treatments
First Use Anywhere: Oct 16, 2019
First Use in Commerce: Oct 16, 2019

Additional Information

Design Mark
The mark consists of the stylized blue lowercase wording "ELEVAR" above the stylized gray lowercase wording "THERAPEUTICS". Above the letters "A" and "R" in "ELEVAR" is the stylized design of wings in the gradient colors of blue, light blue and dark blue depicting a bird.
Color Claim
The color(s) blue, light blue, dark blue and gray is/are claimed as a feature of the mark.
Translation
The English translation of the word "ELEVAR" in the mark is "to raise".

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"